Ahmet Bilici
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy (NCT04765124) | Ahmet Bilici | 2021-04-29 |
Track Ahmet Bilici automatically
Every clearance here is in the API, with alerts when new ones post.